FIELD: medicine.
SUBSTANCE: invention refers to a compound of formula (I) or to its pharmaceutically acceptable salt: formula (I) wherein; R1 represents hydrogen; R2 represents phenyl, benzothienyl, benzofuranyl or the group -CH2CH2-phenyl; wherein R2 is optionally substituted by 1 or 2 substitutes optionally specified in F, O, Br, I, -CN, -NO2, -OR8, C1-C6alkyl and -N(R9)2; R4 represents phenyl substituted by 1 or 2 substitutes optionally specified in F, CI, Br, I, -CP3, -OH, -OR8 and C1-C6alkyl; each R8 is optionally specified in C1-C6alkyl; and each R9 is optionally specified in H and C1-C6alkyl. The invention also refers to a pharmaceutical composition for activity modulation of depot-controlled calcium channels (SOC-channels) containing such compounds.
EFFECT: there are produced new compounds and based pharmaceutical compositions which can find application in medicine for treating the diseases or conditions, such as rheumatoid arthritis, psoriasis, inflammatory intestinal disease, asthma and multiple sclerosis.
12 cl, 21 dwg, 1 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES | 2006 |
|
RU2451009C2 |
OXYGEN-SUBSTITUTED DERIVATIVES OF 3-HETEROAROYLAMINOPROPIONIC ACIDS AND THEIR APPLICATION AS PHARMACEUTICAL SUBSTANCES | 2011 |
|
RU2561126C2 |
OXATHIEPINO[6,5-B]DIHYDROPYRIDINES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2257388C2 |
BENZOQUINAZOLINE DERIVATIVES AND USE THEREOF IN TREATING BONE DISORDERS | 2006 |
|
RU2416602C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2009 |
|
RU2538041C2 |
SUBSTITUTED DERIVATIVES OF 3-THIAZOLAMINEPROPIONIC ACID AND THEIR USE AS PHARMACEUTICALS | 2012 |
|
RU2617843C2 |
ACIDIFIED INDANYLAMINES AND THEIR USE AS PHARMACEUTICAL PREPARATIONS | 2002 |
|
RU2339614C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
KYNURENINE-3-MONOOXYGENASE INHIBITORS | 2009 |
|
RU2523448C2 |
DERIVATIVES OF DITHIEPINO[6,5-B]PYRIDINE, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR INHIBITION AND TREATMENT OF DISORDERS | 2000 |
|
RU2230746C2 |
Authors
Dates
2012-10-27—Published
2008-08-15—Filed